Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Urban Health
Published in: Journal of Urban Health 1/2011

01-02-2011

Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges

Authors: Lindsay M. Jenkins, Caleb J. Banta-Green, Charles Maynard, Susan Kingston, Michael Hanrahan, Joseph O. Merrill, Phillip O. Coffin

Published in: Journal of Urban Health | Issue 1/2011

Login to get access

Abstract

Opioid-involved overdose deaths are on the rise, both nationwide and in the state of Washington. In a survey of 443 participants at syringe exchanges in Seattle, Washington, 16% had overdosed in the last year. Several factors were significantly associated in bivariate analysis: lack of permanent housing; incarceration of five or more days in the past year; gender of sex partners; sharing of syringes and other injection paraphernalia; use of speedballs (cocaine and heroin together), goofballs (methamphetamine and heroin together), buprenorphine; injection use of crack cocaine and sedatives; and use of opioids with sedatives. Adjusting for other variables in multivariate logistic regression analyses, only recent incarceration and sharing of injection materials were still significantly associated with overdose. Correctional facilities, syringe exchange programs, and other agencies serving opioid injectors should include overdose prevention components in release planning and services.
Literature
1.
2.
Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. Hyattsville, MD: National Center for Health Statistics; (NCHS) 2009. (NCHS) data brief 22.
3.
Washington State Department of Health. Poisoning and drug overdose. In: The health of Washington State. A Statewide Assessment of Health Status, Health Risks, and Health Care Services. Olympia, WA: Washington State Dept of Health; 2007.
4.
5.
Public Health—Seattle and King County. Drug-caused death data. Data analyzed. In: Caleb B-G, ed. Alcohol and Drug Abuse Institute. Seattle: University of Washington; 2009.
6.
United States Department of Health and Human Services. National Institute of Health. National Institute on Drug Abuse (2010). Proceedings of the Community Epidemiology Work Group. Bethesda, MD: National Institute on Drug Abuse (in press). (Note: data are based upon weighted estimates for 12 DAWN ED areas for 2007).
7.
Werb D, Kerr T, Lai C, Montaner J, Wood E. Nonfatal overdose among a cohort of street-involved youth. J Adolesc Health. 2008; 42(3): 303–306.CrossRefPubMed
8.
Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007; 87(1): 39–45.CrossRefPubMed
9.
Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005; 80(3): 297–302.CrossRefPubMed
10.
Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007; 14(7): 616–623.PubMed
11.
Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001; 91(11): 1842–1846.CrossRefPubMed
12.
Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction. 1996; 91(3): 405–411.CrossRef
13.
Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001; 26(3): 453–460.CrossRef
14.
Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. J Urban Health. 2007; 84(2): 283–291.CrossRefPubMed
15.
Darke S, Williamson A, Ross J, Teesson M. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005; 24(5): 425–432.CrossRefPubMed
16.
Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001; 322(7291): 895–896.CrossRefPubMed
17.
Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav. 2006; 31(5): 907–912.
18.
Baca CT, Grant KJ. Take-home naloxone to reduce heroin death. Addiction. 2005; 100(12): 1823–1831.CrossRefPubMed
19.
Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005; 82(2): 303–311.PubMed
20.
Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006; 25(3): 89–96.CrossRefPubMed
21.
Piper TM, Rudenstine S, Stancliff S, et al. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J. 2007; 4: 3.CrossRefPubMed
22.
Buajordet I, Naess AC, Jacobsen D, Brørs O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004; 11(1): 19–23.CrossRefPubMed
23.
Yealy DM, Paris PM, Kaplan RM, Heller MB, Marini SE. The safety of prehospital naloxone administration by paramedics. Ann Emerg Med. 1990; 19(8): 902–905.CrossRefPubMed
24.
25.
Binswanger IA, Stern MF, Deyo RA, et al. Release from prison—a high risk of death for former inmates. N Engl J Med. 2007; 356(2): 157–165.CrossRefPubMed
26.
Lloyd-Smith E, Kerr T, Zhang R, Montaner JS, Wood E. High prevalence of syringe sharing among street involved youth. Addict Res Theory. 2008; 16(4): 353–358.CrossRef
27.
Wood E, Tyndall MW, Spittal PM, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002; 16(6): 941–943.CrossRefPubMed
28.
Valente TW, Vlahov D. Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health. 2001; 91(3): 406–411.CrossRefPubMed
29.
Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004; 99(9): 1136–1146.CrossRefPubMed
30.
Donoghoe MC, Dolan KA, Stimson GV. Life-style factors and social circumstances of syringe sharing in injecting drug users. Br J Addict. 1992; 87(7): 993–1003.CrossRefPubMed
31.
Wood E, Tyndall MW, Stoltz J, et al. Factors associated with syringe sharing among users of a medically supervised safer injecting facility. Am J Infect Dis. 2005; 1(1): 50–54.CrossRef
32.
Frischer M, Goldberg D, Rahman M, Berney L. Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1994. Addiction. 1997; 92(4): 419–427.PubMed
33.
Kral AH, Lorvick J, Edlin BR. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr. 2000; 24(2): 162–167.PubMed
34.
Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997; 92(11): 1457–1465.CrossRefPubMed
35.
Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(Suppl 1): S11–S19.PubMed
36.
Banta-Green CJ, Jackson TR, Freng S, Hanrahan M, Albert DH, Haruff R, Kingston S, Forbes A, Miller S, Burt R, Thiede H. Recent drug abuse trends in the Seattle-King County area, June 2007 Seatle: Alcohol & Drug Abuse Institute, University of Washington, June 2007, 17 pp. Accessed online Nov 27 2009 at: http://​adai.​washington.​edu/​pubs/​cewg/​ban07_​02.​pdf.
37.
US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National survey on drug use and health, 2007. Washington, DC: US Dept of Health and Human Services; 2007 .
38.
Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998; 51(3): 253–263. discussion 267–268.CrossRefPubMed
39.
Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994; 1: 383–392.
40.
Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993; 88(4): 517–526.CrossRefPubMed
41.
Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use. JAMA. 1992; 268(17): 2374–2375; author reply 2375–2376.
Metadata
Title
Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges
Authors
Lindsay M. Jenkins
Caleb J. Banta-Green
Charles Maynard
Susan Kingston
Michael Hanrahan
Joseph O. Merrill
Phillip O. Coffin
Publication date
01-02-2011
Publisher
Springer US
Published in
Journal of Urban Health / Issue 1/2011
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-010-9525-6

Other articles of this Issue 1/2011

Journal of Urban Health 1/2011 Go to the issue

Report

Targeting Social and Economic Correlates of Cancer Treatment Appointment Keeping among Immigrant Chinese Patients

OriginalPaper

Prevalence and Predictors of Physical Inactivity in a Slum in Brazil

OriginalPaper

Racism, Health Status, and Birth Outcomes: Results of a Participatory Community-Based Intervention and Health Survey

OriginalPaper

Spatial Clustering of HIV Prevalence in Atlanta, Georgia and Population Characteristics Associated with Case Concentrations

OriginalPaper

Social Network Characteristics and HIV Sexual Risk Behavior among Urban African American Women

OriginalPaper

A Qualitative View of Drug Use Behaviors of Mexican Male Injection Drug Users Deported from the United States